I guess the BOD has no choice but to recommend the revised offer as it is now in line with the expert report.
That said I'm my distrust in the board is growing as is my disappointment with their lack of results and their lack of communication.
This latest offer gives me a 100% profit but that isn't why I invested. I'm here for multiples of that and we can all see with the right people at the helm it's possible.
Its a big fat NO from me and a full replacement of the board would be in our best interests as well!
- Forums
- ASX - By Stock
- RAP
- Ann: Increased Scheme Consideration from Pfizer
Ann: Increased Scheme Consideration from Pfizer, page-95
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online